vs
Side-by-side financial comparison of MEDIFAST INC (MED) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $75.1M, roughly 1.0× MEDIFAST INC). On growth, Repay Holdings Corp posted the faster year-over-year revenue change (0.4% vs -36.9%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $-6.6M). Over the past eight quarters, Repay Holdings Corp's revenue compounded faster (-1.3% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
MED vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $78.6M |
| Net Profit | — | $-140.1M |
| Gross Margin | 69.4% | 74.2% |
| Operating Margin | -10.4% | -182.2% |
| Net Margin | — | -178.3% |
| Revenue YoY | -36.9% | 0.4% |
| Net Profit YoY | — | -3304.1% |
| EPS (diluted) | $-1.64 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $78.6M | ||
| Q3 25 | $89.4M | $77.7M | ||
| Q2 25 | $105.6M | $75.6M | ||
| Q1 25 | $115.7M | $77.3M | ||
| Q4 24 | $119.0M | $78.3M | ||
| Q3 24 | $140.2M | $79.1M | ||
| Q2 24 | $168.6M | $74.9M | ||
| Q1 24 | $174.7M | $80.7M |
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $-2.3M | $-6.4M | ||
| Q2 25 | $2.5M | $-102.3M | ||
| Q1 25 | $-772.0K | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $1.1M | $3.2M | ||
| Q2 24 | $-8.2M | $-4.1M | ||
| Q1 24 | $8.3M | $-5.2M |
| Q4 25 | 69.4% | 74.2% | ||
| Q3 25 | 69.5% | 74.4% | ||
| Q2 25 | 72.6% | 75.7% | ||
| Q1 25 | 72.8% | 75.9% | ||
| Q4 24 | 74.1% | 76.3% | ||
| Q3 24 | 75.4% | 77.8% | ||
| Q2 24 | 73.2% | 78.2% | ||
| Q1 24 | 72.8% | 76.2% |
| Q4 25 | -10.4% | -182.2% | ||
| Q3 25 | -4.6% | -3.9% | ||
| Q2 25 | -1.0% | -138.7% | ||
| Q1 25 | -1.1% | -4.7% | ||
| Q4 24 | 0.6% | -1.5% | ||
| Q3 24 | 1.5% | -0.9% | ||
| Q2 24 | -4.7% | -4.6% | ||
| Q1 24 | 4.5% | -3.1% |
| Q4 25 | — | -178.3% | ||
| Q3 25 | -2.5% | -8.3% | ||
| Q2 25 | 2.3% | -135.2% | ||
| Q1 25 | -0.7% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 0.8% | 4.1% | ||
| Q2 24 | -4.8% | -5.4% | ||
| Q1 24 | 4.8% | -6.5% |
| Q4 25 | $-1.64 | $-1.68 | ||
| Q3 25 | $-0.21 | $-0.08 | ||
| Q2 25 | $0.22 | $-1.15 | ||
| Q1 25 | $-0.07 | $-0.09 | ||
| Q4 24 | $0.08 | $-0.04 | ||
| Q3 24 | $0.10 | $0.03 | ||
| Q2 24 | $-0.75 | $-0.04 | ||
| Q1 24 | $0.76 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $198.9M | $484.4M |
| Total Assets | $248.0M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $115.7M | ||
| Q3 25 | $173.5M | $95.7M | ||
| Q2 25 | $162.7M | $162.6M | ||
| Q1 25 | $164.6M | $165.5M | ||
| Q4 24 | $162.3M | $189.5M | ||
| Q3 24 | $170.0M | $168.7M | ||
| Q2 24 | $163.5M | $147.1M | ||
| Q1 24 | $156.4M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | $198.9M | $484.4M | ||
| Q3 25 | $214.7M | $616.9M | ||
| Q2 25 | $216.0M | $633.7M | ||
| Q1 25 | $211.0M | $755.7M | ||
| Q4 24 | $210.1M | $761.3M | ||
| Q3 24 | $207.3M | $754.7M | ||
| Q2 24 | $205.3M | $815.4M | ||
| Q1 24 | $211.0M | $813.8M |
| Q4 25 | $248.0M | $1.2B | ||
| Q3 25 | $268.2M | $1.3B | ||
| Q2 25 | $269.3M | $1.4B | ||
| Q1 25 | $280.0M | $1.5B | ||
| Q4 24 | $284.2M | $1.6B | ||
| Q3 24 | $291.2M | $1.6B | ||
| Q2 24 | $293.5M | $1.5B | ||
| Q1 24 | $302.8M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $23.3M |
| Free Cash FlowOCF − Capex | $-6.6M | $23.2M |
| FCF MarginFCF / Revenue | -8.8% | 29.6% |
| Capex IntensityCapex / Revenue | 1.8% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $23.3M | ||
| Q3 25 | $12.1M | $32.2M | ||
| Q2 25 | $-3.4M | $33.1M | ||
| Q1 25 | $3.4M | $2.5M | ||
| Q4 24 | $-4.9M | $34.3M | ||
| Q3 24 | $9.1M | $60.1M | ||
| Q2 24 | $13.1M | $31.0M | ||
| Q1 24 | $7.3M | $24.8M |
| Q4 25 | $-6.6M | $23.2M | ||
| Q3 25 | $10.8M | $32.1M | ||
| Q2 25 | $-4.8M | $33.0M | ||
| Q1 25 | $1.9M | $2.4M | ||
| Q4 24 | $-7.2M | $34.0M | ||
| Q3 24 | $7.7M | $59.8M | ||
| Q2 24 | $11.1M | $30.5M | ||
| Q1 24 | $5.4M | $24.7M |
| Q4 25 | -8.8% | 29.6% | ||
| Q3 25 | 12.0% | 41.3% | ||
| Q2 25 | -4.5% | 43.6% | ||
| Q1 25 | 1.6% | 3.0% | ||
| Q4 24 | -6.1% | 43.5% | ||
| Q3 24 | 5.5% | 75.6% | ||
| Q2 24 | 6.6% | 40.7% | ||
| Q1 24 | 3.1% | 30.6% |
| Q4 25 | 1.8% | 0.1% | ||
| Q3 25 | 1.5% | 0.2% | ||
| Q2 25 | 1.3% | 0.1% | ||
| Q1 25 | 1.3% | 0.2% | ||
| Q4 24 | 1.9% | 0.3% | ||
| Q3 24 | 1.0% | 0.3% | ||
| Q2 24 | 1.1% | 0.6% | ||
| Q1 24 | 1.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
